Manulife China Bank Life champions early health action and financial planning at The Art of Longevity. - Manulife China Bank Life brought together health, wealth, and protection experts to help customers plan for a more secure future. Manulife China Bank Life Assurance Corporation (MCBL), the strategic alliance between Manulife Philippines and China Banking Corporation, hosted The Art of Longevity on August 11, 2026, an event that brought together more than a hundred MCBL customers, financial sales associates, bank partners, and health and wealth experts to explore how to plan for a longer, healthier future. As Filipinos live longer, The Art of Longevity underscored the need for long-term planning in two areas: proactive health management through prevention and early detection, and building financial resilience and preparedness to support the years ahead. "Living longer is a gift, but it also requires more intentional planning so people can make the most of every stage of life. Health, protection, and financial confidence must work together to support the future our customers want. Through The Art of Longevity, MCBL is bringing together the right conversations, partners, and solutions to help Filipinos take practical steps sooner. By empowering more people to act early, we can help them live better for longer," said Amy Gochuico, President and Chief Executive Officer, Manulife China Bank Life. The event also raised awareness of cancer as a major health challenge that can affect longevity and emphasized the importance of taking early steps to prevent, detect, and manage health risks. According to a recent Manulife Philippines study, cancer is one of the most feared diseases among Filipinos. Yet, many delay screenings. A 2023 report by the Philippine Institute for Development Studies also noted that only 1% of Filipino women go through cancer screening. Cancer is often found only in its later stages, and in the Philippines, 65% of breast cancer cases are only diagnosed when it is in its advanced stages. Together with healthcare partners Ayala Health Holdings, Inc. (AC Health), Healthway Cancer Care Hospital, and Guardant Health, the discussion looked at how cancer risk can build up over time, why early detection matters, and how newer tests and coordinated care are helping people act sooner. Building on this focus, the event also highlighted MCBL's recently launched partnership with Guardant Health, which gives eligible customers access to Shield(TM) Multi-Cancer Detection laboratory developed test. The conversations broadened the discussion from early detection to the everyday choices, coordinated care, and long-term financial planning that can help people sustain both health and wealth over a longer lifespan. The event also reinforced the importance of financial preparedness as markets shift and lifespans extend. This focus on longer-term planning reflects the role of MCBL's bancassurance model in helping customers connect protection, savings, and wealth-building needs. By bringing together Manulife's insurance and protection solutions with Chinabank's banking and wealth-building expertise, MCBL helps Filipinos create plans that support their life goals and strengthen their financial future. The Art of Longevity is aligned with ManulifeMOVE, the company's holistic health program, and reflects MCBL's role as a lifelong partner helping Filipinos care for both their health and financial future through solutions tailored to their needs. It also aligns to the Manulife Longevity Institute, a global research, thought leadership, innovation, advocacy, and community partnership platform, which drives action to help people live longer, healthier, and more financially secure lives.

Manulife Financial Co. (TSE:MFC) receives consensus rating of "Buy" from analysts. August 13, 2026 Key points. * Analysts have a consensus "Buy" rating on Manulife Financial, with 10 buy ratings, one strong-buy rating and one hold rating among 12 firms. The average 12-month price target is C$66.00. * Several major brokerages recently raised their targets, with Scotia, RBC, National Bank Financial, Jefferies and BMO setting objectives between C$67 and C$70. * Manulife reported quarterly EPS of C$1.09 on C$20.34 billion in revenue, while its shares opened at C$61.06 and were trading near their 52-week high of C$63.58. * MarketBeat previews the top five stocks to own by September 1st. Manulife Financial Co. (TSE:MFC - Get Free Report) NYSE: MFC has been assigned a consensus recommendation of "Buy" from the twelve research firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is C$66.00. A number of research analysts recently weighed in on MFC shares. Scotia boosted their target price on Manulife Financial from C$61.00 to C$67.00 and gave the stock a "sector outperform" rating in a report on Friday, August 7th. Royal Bank Of Canada raised their price target on Manulife Financial from C$55.00 to C$67.00 and gave the company an "outperform" rating in a report on Friday, August 7th. National Bank Financial lifted their price objective on shares of Manulife Financial from C$59.00 to C$69.00 and gave the stock an "outperform" rating in a research report on Thursday, July 23rd. Jefferies Financial Group upped their target price on Manulife Financial from C$61.00 to C$70.00 and gave the company a "buy" rating in a research report on Tuesday, July 21st. Finally, BMO Capital Markets raised their price target on shares of Manulife Financial from C$67.00 to C$70.00 and gave the stock an "outperform" rating in a research report on Friday, August 7th. Manulife Financial stock up 0.0%. Shares of MFC stock opened at C$61.06 on Thursday. Manulife Financial has a 52-week low of C$41.22 and a 52-week high of C$63.58. The stock has a market cap of C$101.31 billion, a price-to-earnings ratio of 16.55, a PEG ratio of 1.01 and a beta of 0.71. The firm's 50-day moving average is C$58.92 and its 200-day moving average is C$53.49. The company has a debt-to-equity ratio of 26.52, a quick ratio of 2.58 and a current ratio of 2.36. Manulife Financial (TSE:MFC - Get Free Report) NYSE: MFC last released its quarterly earnings data on Wednesday, August 5th. The financial services provider reported C$1.09 earnings per share (EPS) for the quarter. Manulife Financial had a return on equity of 12.98% and a net margin of 11.62%.The firm had revenue of C$20.34 billion for the quarter. Sell-side analysts predict that Manulife Financial will post 3.6104452 EPS for the current year. Insider buying and selling. In other Manulife Financial news, Director Anthony Alex Silva bought 2,334 shares of the business's stock in a transaction on Thursday, May 21st. The stock was purchased at an average cost of C$53.16 per share, for a total transaction of C$124,075.44. Following the completion of the purchase, the director directly owned 8,175 shares of the company's stock, valued at approximately C$434,583. This trade represents a 39.96% increase in their ownership of the stock. Also, Director Eileen Cloherty sold 6,500 shares of the company's stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of C$53.45, for a total value of C$347,425.00. Following the sale, the director owned 3,412 shares of the company's stock, valued at approximately C$182,371.40. This represents a 65.58% decrease in their ownership of the stock. Insiders sold 136,834 shares of company stock worth $7,311,659 in the last ninety days. 0.03% of the stock is owned by company insiders. About Manulife Financial. Manulife Financial Corporation, a leading international financial services provider that helps people make their decisions easier and lives better by providing financial advice, insurance, and wealth and asset management solutions. Manulife Financial Corporation trades as MFC on the TSX, NYSE, and PSE, and under 945 on the SEHK. Manulife can be found at manulife.com. One of the largest life insurers in the United States, John Hancock supports more than ten million Americans with a broad range of financial products, including life insurance and annuities. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Discover more Earnings screener tool Derivatives Dividend screener tool Continue following MarketBeat Before you consider Manulife Financial, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Manulife Financial wasn't on the list. While Manulife Financial currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys. Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain - combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.